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Willingness to get vaccinated against Covid-19: profiles and 
attitudes towards vaccination 
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Abstract  
Background: High uptake of a Covid-19 vaccine is required for a successful vaccination campaign that 
manages to reach herd immunity.  
Objective: To identify the predictors associated with someone’s willingness to get vaccinated against 
Covid-19, and to investigate whether these coincide with the predictors of attitudes towards vaccination 
in general.  
Methods: A representative sample of 2,060 Belgians were surveyed between 6 and 16 October 2020. 
Regression analyses were used to calculate adjusted and non-adjusted odds ratios of variables associated 
to someone’s willingness to become vaccinated and to vaccine attitudes in general.  
Results: 34% (n=651) of the participants reported that they will definitely get vaccinated against Covid-
19 once a vaccine is available and 39% (n=742) that they would “probably”. Intended uptake was 
strongly associated with age, opinion on the government’s dealing with the Covid-19 pandemic, medical 
risk and spoken language, and to a lesser extent with gender and having known someone who was 
hospitalised because of Covid-19. Similar predictors were identified for attitudes to vaccination in 
general. However, Covid-19 vaccine hesitancy was more marked in age groups below 54 years old. We 
further analysed a sample of 17% (n=349) of the participants found favourable to vaccination in general 
but not willing to vaccinate against Covid-19. These people were mainly female, young, French 
speaking, slightly less educated, and working. They also did not belong to a Covid-19 risk group, were 
very dissatisfied with the government’s dealing with the Covid-19 crisis, and did not know personally 
someone who was hospitalized because of Covid-19.  
Conclusions: The majority of Belgians intend to get vaccinated, though uptake is lower in groups at 
lower risk of severe forms of Covid-19. Levels of vaccine hesitancy seem higher for Covid-19 
vaccination than for other vaccines, with a substantial part of the population being convinced of the 
utility of vaccination in general but nonetheless being hesitant about the Covid-19 vaccine. 
Communication campaigns will need to inform on the safety and efficacy of Covid-19 vaccination to 
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After months of global public health crisis that has paralyzed our societies, safe and effective vaccines 
that protect against Covid-19 are becoming available (Voysey et al. 2020, Polack et al. 2020). The next 
crucial challenge will be to deploy these vaccines with sufficiently high vaccination coverage rates in 
the population so that thresholds required for herd immunity can be reached. For vaccine efficacies of 
approximately 80%, it has been estimated that herd immunity requires that minimally 60% (Altmann, 
Douek, and Boyton 2020) but possibly up to 90% of the population become vaccinated (Anderson et al. 
2020). Herd immunity will not just be a bonus that comes on top of individual vaccine protection. It will 
be an essential layer of Covid-19 prevention on which many people will depend as none of the vaccines 
will be 100% effective, it remains to be seen whether they will be equally effective in all individuals 
and some population subgroups cannot receive vaccination (e.g. for medical reasons).   
The most optimal mechanism to rapidly achieve herd immunity will be mass vaccination. However, 
apart from the logistic challenge of reaching sufficient numbers of individuals, there is an even bigger 
challenge in convincing vaccine hesitant individuals to become vaccinated (McAteer et al. 2020). 
Vaccination has always been controversial and throughout history a part of the population has always 
resisted it (Marshall 2019). Over the past years, researchers have observed substantial and increasing 
levels of vaccine hesitancy in the population, often linked to the fact that infectious diseases and their 
consequences are fading from public memory but also in part through misinformation propagated on the 
internet (Horne et al. 2015, Luyten, Bruyneel, and van Hoek 2019). The World Health Organization 
(WHO) labelled vaccine hesitancy one of the top ten threats to global health in 2019, next to e.g. 
antimicrobial resistance or air pollution and climate change. Also with the COVID-19 vaccine, policy 
makers dealing with vaccine hesitancy and scepticism will be a critical success factor (WHO 2018).  
Therefore, it is important that policy makers have a good view on the people profiles who are likely to 
refuse or delay vaccination. This will enable them to target communication campaigns and to devise 
vaccination strategies that take into account the clustering of susceptibility in profiles that are likely to 
refuse.  
This paper aims to identify among a representative sample of the Belgian population the predictors 
associated with the willingness to become vaccinated against Covid-19 and investigate whether these 





We invited a sample of people drawn from a nationally representative panel of the market research 
agency SSI to complete a survey between 6 and 16 October 2020. The continuously updated panel 
includes 5,500 selected members that mirror the Belgian population (aged 18 – 80 years) as well as 
possible. Our study sample was drawn randomly, fulfilling pre-determined Belgium quota for age, 
gender, level of education and province. The main objective of the survey was to carry out an experiment 
to elicit individual preferences on who should get vaccinated first in the population; the results of the 
experiment are reported elsewhere (Luyten, Tubeuf, and Kessels 2020). In this paper we focus on two 
specific questions about attitudes toward vaccination. Before participants took the experiment, we asked 
them to answer the question “Would you say that vaccination for infectious disease is… very useful, 
rather useful, rather useless, very useless”. Then, at the end of the experiment, we asked the question 
“Once there is a safe and effective Covid-19 vaccine, will you get vaccinated?” and the four responses 
items were “definitely”, “probably”, “probably not”, “definitely not”. The survey also asked respondents 
for a range of sociodemographic characteristics along with their attitudes toward the government’s 
dealing with the corona crisis, whether they had had Covid-19, whether someone they knew had it, was 
hospitalized because of it and had died because of it. Respondents were also asked whether their 
profession was among the “essential professions” (i.e. those that were obliged to keep working during 
the first “lockdown” in March/April 2020) and whether they considered themselves to be part of a risk 
group for Covid-19 and if so, which group they belonged to (old age, chronic illness, obesity, or other). 
Respondents were asked about whom should decide who gets the Covid-19 vaccine first (government, 
scientists or the population), whether they would choose to be vaccinated themselves once a vaccine 
becomes available, and how easy they found answering the survey.  
2.2. Data analysis  
We considered willingness to get Covid-19 vaccinated as a binary variable grouping the answers 
“definitely” against “probably”, “probably not” and “definitely not”. We determined the factors 
significantly associated to this response using a multivariate regression model with as dependent 
variable whether an individual intends to become vaccinated or (s)he still doubts or refuses to become 
vaccinated. We estimated adjusted and unadjusted odds ratios of willingness to be Covid-19 vaccinated 
using all the variables that showed significance (p<0.05) in a univariate analysis. We repeated the same 
analysis for attitudes toward infectious disease vaccination grouping “very useful” against “rather 
useful”, “rather useless” and “very useless”.  
We then studied the sub-sample of people who exhibited a seemingly inconsistent opinion of being pro 
vaccination in general but being unwilling to take the Covid-19 vaccine once available. We used basic 
descriptive statistics and frequencies to describe all variables, comparing the full sample of survey data 
with the smaller sample of inconsistent individuals. We used chi-square tests to indicate significant 
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differences in proportions between the two samples. We performed all analyses using the JMP Pro 15 
statistical software.  
 
3. Results 
A total of N=2,060 surveys were completed and checked for quality based on respondents’ answers to 
several comment boxes. None were excluded. Overall, 34% (N=651) indicated that they would 
“definitely” become vaccinated with a Covid-19 vaccine and 39% (N=742) stated that they would 
“probably” become vaccinated with a Covid-19 vaccine, 18% (N=346) said “probably not” and 9% 
(N=165) said “definitely not”. The numbers of sceptical answers to Covid-19 vaccination were 
substantially higher than the sceptical answers to the usefulness of vaccination in general. Whereas 73% 
stated to be willing to become vaccinated with the Covid-19 vaccine, 90% stated to think that 
vaccination is useful to protect against infectious diseases. 49% (N=1002) stated that vaccination is 
“very useful” and 41% (N=848) stated it to be “rather useful”. 7% (N=153) said “rather useless” and 
3% (N=57) said “very useless”.  
When carrying out univariate analyses, we found larger discrepancies in different age groups’ 
willingness to be Covid-19 vaccinated compared to their attitude toward vaccination in general. While 
at most 12% of the population across all age groups found vaccination useless (See Figure 1), Covid-
19 vaccine scepticism represented between 30% and 36% among people younger than 54 years old with 
the largest share of sceptics in the 25-34 and 35-44 years old. While there were less Covid-19 vaccine 
sceptics in the older age groups (20% in 55-64 and 13.3% in people above 65), these shares were still 
larger than the shares of people reporting vaccination in general to be useless across any age groups.  
The multivariate logistic regression analyses (Table 1) revealed that factors predicting willingness to 
vaccinate against Covid-19 were being male (Odds Ratio (OR) = 1.53, 95% confidence interval (CI) 
1.25–1.89, p < 0.0001), being Dutch-speaker (OR = 2.37 (1.89-2.95, p < 0.0001), knowing someone 
who was hospitalised for Covid-19 (OR = 1.78 (1.16-2.71), p = 0.0083), and belonging to a medically 
vulnerable group (OR = 1.71 (1.35-2.17), p < 0.0001). The willingness to get Covid-19 vaccinated also 
gradually increased with age groups from age 45 when compared to the younger age category of 18-24 
(45-54 OR = 1.16 (0.75-1.77), 55-64 OR = 1.72 (1.11-2.66), 65 and above OR = 2.26 (1.45-3.53), p < 
0.0001) and with satisfaction toward the government’s response to the health crisis (satisfied OR = 2.94 
(1.61-5.37), rather satisfied OR = 1.55 (1.15-2.10), rather dissatisfied OR = 1.17 (0.87-1.58),  p = 
0.0003). When asked about who should decide about priority access to the Covid-19 vaccine, people 
willing to get vaccinated were more likely to reply government or scientists (respectively OR = 1.58 
(1.00-2.51), OR = 2.14 (1.50-3.06), p < 0.0001) versus the population. 
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Table 1: Unadjusted and adjusted odds ratios of willingness to get Covid-19 vaccinated and of having a non-hesitant attitude towards vaccination in 
general.  
 Covid-19 vaccine acceptance General vaccine acceptance 
Characteristic Unadjusted odds 
ratio (95% CI) 
Adjusted odds 
ratio (95% CI) 
P-value (adjusted) Unadjusted odds 
ratio (95% CI) 
Adjusted odds 
ratio (95% CI) 
P-value (adjusted) 
Male gender 1.55 (1.28-1.87) 1.53 (1.25-1.89) <0.0001 1.26 (1.06-1.50) 1.32 (1.08-1.61) 0.0058 
Dutch language 2.33 (1.90-2.85) 2.37 (1.89-2.95) <0.0001 1.68 (1.41-2.00) 1.54 (1.25-1.90) <0.0001 
Age 
  18-24 
  25-34 
  35-44 
  45-54 
  55-64 
  65-80 
 
































  Basic 
  Third degree sec school 
  Higher 
 
1.00 (reference) 



















Have children 1.22 (1.00-1.49)  NS 1.30 (1.09-1.56)  NS 
Profession 
  Working 
  Homemaker 
  Student 
  Unemployed 
  Disabled 



















Profession is not ‘essential’ 1.40 (1.09-1.81)  NS 1.24 (1.00-1.55)  NS 
Financial difficulties 
  Never 
  Once a year 
  Once every three months 






















government’s approach to 
Covid-19 pandemic  
  Very satisfied 
  Rather satisfied 
  Rather dissatisfied 





































Has had a Covid-19 
infection 
  Yes, confirmed with a test 
  Probably, but not confirmed 
  with a test 

























Know personally someone 
who has had Covid-19 
  Yes, confirmed with a test 
  Probably, but not confirmed  
  with a test 



























Know personally someone 
who was hospitalized for 
Covid-19 
1.60 (1.09-2.35) 1.78 (1.16-2.71) 0.0083 1.04 (0.73-1.49)  NS 
Know personally someone 
who died of Covid-19 
1.31 (0.85-2.04)  NS 1.21 (0.80-1.85)  NS 
Medically vulnerable group 2.61 (2.15-3.18) 1.71 (1.35-2.17) <0.0001 2.34 (1.95-2.81) 1.83 (1.45-2.30) <0.0001 
Determination vaccine 
prioritization  
  Population 
  Government 



























Covid-19 vaccine acceptance    16.44 (12.72-21.24)   
General vaccine acceptance 16.44 (12.72-21.24)      
Note: NS stands for “highly non-significant” (p-value > 0.2) 
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The predicting factors of the willingness to get vaccinated against Covid-19 were mostly similar to the 
predicting factors of reporting that infectious disease vaccination is very useful as illustrated by the 
strong correlation with the very high odds ratio of being both willing to take the Covid-19 and finding 
infectious disease vaccination very useful (OR = 16.44 (12.72-21.24)). While socioeconomic 
characteristics were not identified as predictors of the willingness to vaccinate against Covid-19, 
educational attainment is significantly and increasingly associated with positive opinion about 
vaccination in general (secondary school OR = 1.35 (1.04-1.75), higher education OR = 1.71 (1.32-
2.22), p = 0.0002).  
A sample of N=349 individuals (17%) exhibited an interesting opinion toward vaccination. They 
consider vaccination against infectious diseases very useful (15%, N=52) or rather useful (85%, N=297), 
but report they would definitely not (24%, N=85) or rather not (76%, N=264) vaccinate against Covid-
19. We investigated further who those people were (Table 2).  Compared to the main sample, they were 
more likely to be women (p = 0, 0067), younger than 54 years old (p < 0.0001), French speaking (p < 
0.0001), with first or second degree secondary school (p = 0.0714), working (p < 0.0001), and to believe 
that the population should determine the vaccination priority strategy (p = 0.1030). They were also less 
likely to belong to a Covid-19 risk group (p < 0.0001), to have known someone who was hospitalised 
because of Covid-19 (p = 0.0314), and they were rather or very dissatisfied with the government’s 
dealing with the Covid-19 crisis (p < 0.0001).  
 
Table 2: Descriptive statistics of the full sample and the subsample of contradictory respondents 
who believe vaccination is useful, but who do not wish to become vaccinated against Covid-19.  






Characteristic Responses item N % N %  
Respondents’ general background    
Gender  Female 1055 51% 206 59% p = 0.0067 
Male 1005 49% 143 41% 
Age  18-24 208 10% 41 12% p < 0.0001 
25-34 346 17% 76 22% 
35-44 358 17% 83 24% 
45-54 400 19% 79 22% 
55-64 341 17% 38 11% 
65-80 407 20% 32 9% 
Language Dutch 1174 57% 156 45% p < 0.0001 
French 886 43% 193 55% 
Education  None  8 0% 0 0% p = 0.0714 
Primary school 65 3% 6 2% 
First degree secondary school 208 10% 43 12% 
Second degree secondary school 262 13% 53 15% 
Third degree secondary school 715 35% 120 35% 
Higher education (non-university) 495 24% 81 23% 
University or post-university education 278 14% 45 13% 
PhD 21 1% 0 0% 
Other 8 0% 1 0% 
Have children Yes 1283 62% 208 60% p = 0.3414 
No 777 38% 141 40% 
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Profession  Working 1039 51% 216 62% p < 0.0001 
Homemaker 87 4% 14 4% 
Student 168 8% 28 8% 
Unemployed 138 7% 30 8% 
Disabled 131 6% 20 6% 
Retired 497 24% 41 12% 
Difficulties with monthly 
expenses 
Never  847 41% 124 35% p = 0.2371 
Once a year  447 22% 79 23% 
Once every three months  413 20% 77 22% 
Every month  353 17% 69 20% 
Respondents’ Covid-19 related background    
Self-reported membership 
of a Covid-19 risk group  
 
No 1261 61% 265 76% p < 0.0001 
Yes, elderly 384 19% 28 8% 
Yes, chronically ill 424 21% 52 15% 
Yes, severe obesity 133 6% 14 4% 
Yes, other 69 3% 6 2% 
Self-reported profession is 
labelled as 'essential'  
Yes 393 19% 74 21% p = 0.3575 
No 1667 81% 275 79% 
Has had a Covid-19 
infection 
Yes, confirmed with a test 64 3% 8 2% p = 0.4110 
Probably, but not confirmed with a test 173 8% 24 7% 
No 1823 89% 317 91% 
Know personally someone 
who has had Covid-19 
Yes, confirmed with a test 314 15% 49 14% p = 0.7480 
Probably, but not confirmed with a test 187 9% 35 10% 
No 1559 76% 265 76% 
Know personally someone 
who was hospitalized for 
  
Yes 127 6% 12 3% p = 0.0314 
No 1933 94% 337 97% 
Know personally someone 
who died of Covid-19 
Yes 92 4% 13 4% p = 0.5222 
No 1968 96% 336 96% 
Satisfaction with 
government’s approach to 
Covid-19 pandemic  
Very satisfied 66 3% 2 1% p < 0.0001 
Rather satisfied 774 38% 92 26% 
Rather dissatisfied 827 40% 158 45% 
Very dissatisfied 393 19% 97 28% 
Determination of the 
vaccine prioritization 
strategy 
Population 242 13% 58 17% p = 0.1030 
Government 196 10% 29 8% 
Scientists 1466 77% 262 75% 
$ Chi-square test to indicate significant differences in proportions between the two samples.  
 
4. Discussion 
The majority of Belgians intend to vaccinate against Covid-19, though uptake is lower in groups that 
are at lower risk of severe forms of Covid-19.  However, the vaccine hesitant group may be a key factor 
in whether herd immunity against Covid-19 can be achieved within the population. According to 
Anderson et al. (2020), if a vaccine has approximately 80% efficacy, it is between 75 and 90% of the 
population who needs to be vaccinated and so, the observed share of the population willing to get Covid-
19 vaccinated in this representative sample is not sufficient. 
Some of the many reasons behind vaccine hesitancy are related to the success of vaccines to slowing 
down once devastating diseases have eradicated and as a result, people focus on the perceived risks of 
vaccination as they are less aware of the consequences of not vaccinating (McAteer et al. 2020, Luyten 
et al. 2014). Similarly in the case of Covid-19, hesitancy may be caused by individuals having no 
personal experience of people in their proximity having been critically ill or passing away as a result of 
Covid-19 (Davies 2020). Our results support such statement as we observe that people who know 
 10 
someone who has been hospitalised because of Covid-19 are almost twice more likely to be willing to 
get vaccinated.  
Since there is a clear support for the usefulness of vaccination against infectious diseases in this 
representative sample, we can assume that most of the population is already aware of the collective 
benefit of vaccination. The larger hesitancy toward Covid-19 might therefore be explained by particular 
concerns about the Covid-19 vaccine, e.g. that it has been developed too fast and that the full safety 
profile of the vaccine is not (yet) entirely understood. As such a larger than usual share of the general 
public may prefer not to vaccinate until they feel they can make a more informed vaccination decision. 
If anything, this result calls for communication campaigns that comfort people on the safety and efficacy 
of Covid-19 vaccination to encourage uptake.   
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